IPs were performed as previously described (64): Cells were disrupted with a Fastprep (MP) Biomedicals, and proteins were precipitated on appropriately coated Dynabeads (Invitrogen) following the instructions of the manufacturer for 2 hours and washed four times in NP-40 buffer [6 mM Na2HPO4, 4 mM NaH2PO4, 1% Nonidet P-40, 150 mM NaCl, 2 mM EDTA, and 50 mM NaF supplemented with complete EDTA-free and PhosSTOP tablets (Roche)] and once in kinase buffer [10 mM MgCl2, 50 mM tris-HCl (pH 7.5), 2 mM dithiothreitol, 1 mM EDTA, and 1 mM EGTA] before the kinase reaction in kinase buffer supplemented with 1 μl of γ32P-ATP (adenosine triphosphate; 3000 Ci/mmol), 100 μM ATP, and 1 μg of Elp4 peptide (corresponding to 1 μl). Peptides were synthetized by Eurogentec with the following sequences: Elp4, SAGEDNHSSPPSKN; Elp4, S118-P SAGEDNHSSPPS(Ph)KN; Elp4, S114A S118-P SAGEDNHASPPS(Ph)KN; and Elp4, S115A S118-P SAGEDNHSAPPS(Ph)KN. The assay was performed for 30 min at 30°C and separated on tris-Tricine gel (Bio-Rad). GST-Gsk3 fusion proteins were expressed from pGEX4T1 and purified following the instructions of the manufacturer (GE Healthcare).

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.